title: Psychotropic medications and substances of abuse interactions in youth.
abstract: The majority of youth with substance use disorders (SUDs) manifest one or more co-occurring psychiatric disorders. Consequently, many of these youths are being prescribed with psychotropic medications. As prescribing rates continue to increase for early-onset psychiatric disorders, potential risk for substance of abuse-psychiatric medication interactions may be enhanced. Because this type of drug-drug interaction has received little attention in the scientific literature, the authors conducted a systematic literature search examining the potential interactive adverse effects between psychotropic medications and substances of abuse in youth. Regardless of the scarcity of psychotropic medications-substance of abuse interactions found, it is important to stay vigilant due to the continued introduction of new classes of medications as well as the ever-changing map of street drugs.
authors.affiliation: Alcohol Research Center, University of Connecticut Health Center, Farmington, Connecticut 06030-2103, USA. kaminer@uchc.edu
authors.forename: Yifrah
authors.initials: Y
authors.lastname: Kaminer
authors.forename: Pablo
authors.initials: P
authors.lastname: Goldberg
authors.forename: Daniel F
authors.initials: DF
authors.lastname: Connor
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D017831:Diagnosis, Dual (Psychiatry) / Q000009:adverse effects*; D004347:Drug Interactions; D006801:Humans; D013287:Illicit Drugs / Q000009:adverse effects*; D007223:Infant; D011619:Psychotropic Drugs / Q000009:adverse effects*
chemical_list: D013287:Illicit Drugs; D011619:Psychotropic Drugs
references.citation: J Adolesc Health. 2007 Jan;40(1):76-83
references.pmid: 17185209
references.citation: J Am Acad Child Adolesc Psychiatry. 1997 Jan;36(1):45-8
references.pmid: 9000780
references.citation: J Child Adolesc Psychopharmacol. 2005 Oct;15(5):787-98
references.pmid: 16262595
references.citation: Am J Orthopsychiatry. 2005 Oct;75(4):676-83
references.pmid: 16262523
references.citation: Clin Toxicol. 1975;8(4):405-56
references.pmid: 1220895
references.citation: Addict Behav. 2006 Mar;31(3):461-74
references.pmid: 15972246
references.citation: Arch Gen Psychiatry. 1988 Jun;45(6):581-8
references.pmid: 3377645
references.citation: Br J Clin Pharmacol. 1996 Aug;42(2):239-41
references.pmid: 8864325
references.citation: J Am Acad Child Adolesc Psychiatry. 2006 Apr;45(4):408-14
references.pmid: 16601645
references.citation: Arch Intern Med. 2008 Jul 28;168(14):1561-6
references.pmid: 18663169
references.citation: J Consult Clin Psychol. 2009 Apr;77(2):281-90
references.pmid: 19309187
references.citation: Addict Behav. 2005 Oct;30(9):1824-33
references.pmid: 16102905
references.citation: Arch Pediatr Adolesc Med. 2007 Nov;161(11):1026-34
references.pmid: 17984403
references.citation: J Am Acad Child Adolesc Psychiatry. 2008 Jul;47(7):745-754
references.pmid: 18520963
references.citation: Addiction. 2003 Nov;98(11):1493-504
references.pmid: 14616175
references.citation: Harv Rev Psychiatry. 1997 Jan-Feb;4(5):231-44
references.pmid: 9385000
references.citation: Addiction. 2000 Mar;95(3):407-17
references.pmid: 10795361
references.citation: Biol Psychiatry. 2004 Nov 15;56(10):714-7
references.pmid: 15556111